Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse Files for FDA Clearance of Molecular Metapneumovirus Assay

NEW YORK (GenomeWeb News) – Prodesse has filed with the US Food and Drug Administration for 510(k) clearance of its real-time PCR-based Pro hMPV+ Assay for rapid detection of human metapneumovirus.
 
Prodesse said that the assay can provide accurate results in as little as three hours compared to days or weeks for non-molecular methods. hMPV was discovered in 2001 and causes acute respiratory illness. Its prevalence ranges from 6.6 percent to 12 percent annually of patients with symptoms of respiratory infection.
 
The Milwaukee, Wis.-based firm did not say when it expects to receive clearance for the assay.
 
In January, Prodesse received FDA clearance for its ProFlu+ Assay. It currently is developing additional tests for differentiating parainfluenza 1, 2, and 3 viruses and adenovirus.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.